Overview

Effect of Cenicriviroc on HIV Neurocognitive Impairment

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The study hypothesis is that cenicriviroc will improve cognition in HIV infected individuals with cognitive impairment. The investigators will study the effect of cenicriviroc on cognition in 24 subjects over a 24 week period.
Phase:
Phase 2
Details
Lead Sponsor:
University of Hawaii
Collaborator:
Tobira Therapeutics, Inc.
Treatments:
Cenicriviroc
TAK-652